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Abstract

THE EXTRACTION OF TYPE I1 COLLAGEN AND THE ELECTROSPINNING OF
NANO-FIBROUS SCAFFOLDS
By Danielle Careen Knapp, M.S.
A thesis submitted in partial fulfillment of the requirements for the degree of Master of
Science in Biomedical Engineering at Virginia Commonwealth University.
Virginia Commonwealth University, 2005.
Major Director: Gary L. Bowlin, Ph.D., Associate Professor, Louis and Ruth Harris
Exceptional Professorship, Biomedical Engineering

Articular cartilage lining joints, such as in the knee, functions to reduce friction
and absorb shock. Collagen type I1 is the largest constituent in the extracellular matrix of
articular cartilage and its restoration is of the highest interest to tissue engineers.
Cartilage has little ability to naturally regenerate due to the absence of vascularity and the
inability of the chondrocytes to proliferate at a high rate. It would be ideal to create a
mimicking extracellular matrix/scaffold from type I1 collagen that could possibly be used
to replace damaged articular cartilage that has the same function and morphology. Three
different groups of cartilage chips were utilized to extract type I1 collagen. The yield of
the three groups was compared. The extracted type I1 collagen from the three groups was
electrospun at the concentrations of 0.06,0.08,0.10 and 0.12 g/mL. Both the pore size

and fiber diameter were analyzed. A SDS-Page was performed on the material to assure
it was pure type I1 collagen and that no collagen type I contamination was present.

Introduction and Background

Researchers have utilized electrospinning over the years for materials that are
both natural and synthetic in nature. Articular cartilage has proven to be a large problem
located in the knees of aging individuals. This tissue is unable to easily regenerate
naturally due to the absence of vascularity and the inability of chondrocytes to proliferate
at a high rate. It is highly desirable to find a way to create a scaffold that could mimic the
morphology and function of natural articular cartilage. Because articular cartilage is
composed mainly of type I1 collagen, this material was electrospun into multiple
scaffolds with varying fiber diameter and pore size in order to find an optimal
extracellular matrix that could possibly be seeded with chondrocytes, potentially creating
tissue engineered cartilage.
Anatomy of Articular Cartilage

Research over the years has proven that there are over 27 collagen types. Every
collagen molecule is made up of three alpha chains wound in a triple helix configuration.
Collagen type I1 consists of three specific alpha1 (11) chains that form its right-handed
triple helix configuration. Type I1 collagen is of the highest concentration in articular
cartilage. This tissue can be found at the ends of all articulatingjoints such as the tibia
and femur. Articular cartilage is the thin layer of connective tissue that covers the
surfaces of the bones in the synovial joints. This layer varies in thickness according to its
location, ranging from one rnrn in the finger joint up to six rnm in the knee joint (Hasler
1

et al. 4 16). Articular cartilage functions to transmit weight-bearing loads placed on the
joints in the body from one bone to another. This allows the stresses on the subchondral
bone to be correctly distributed and allows for low friction movement. There are high
amounts of cyclic stresses that are induced on all the joints in the body (knee joint in
particular), on a daily basis. The structure and composition of articular cartilage are what
allows this tissue to properly function inside the body.
The composition of articular cartilage includes cells that are referred to as
chondrocytes, which are imbedded in the extracellular matrix. The unique quality of
articular cartilage is that it is completely aneural and avascular. Cartilage receives its
nutrients via diffusion from the synovial fluid. In mature adult cartilage, chondrocytes
make up only 10% of the total volume (Hasler et al. 417). The rest of the extracellular
matrix is composed of water, electrolytes, collagens, proteoglycans, and glycoproteins.
Proteoglycans are large biomolecules composed of a long protein core and
glycosaminoglycan chains that are attached along its length. The protein core only makes
up 10% of the molecular weight of the proteoglycans, and the glycosaminoglycan chains
make up the other 90%. The glycosaminoglycan chains hold a highly negative charge,
which allows the proteoglycans to have a high charge density, giving rise to a large
osmotic swelling pressure. There are two main types of proteoglycans present in
cartilage. The first is a larger set that includes aggrecan and versican and a smaller set
that includes biglycan, decorin, fibromodulin, and lumican. The most abundant
proteoglycan overall is aggrecan, which is made up of a protein core with chondriotin
sulfate and keratin sulfate chains attached along its length. An illustration of a
proteoglycan aggregate can be seen below in Figure 1.

Proteoglycan Aggregate Molecule

binding Region
Hyaluronate

Sulfate Rich Region
Chondroitin sulfate rich region

Link Proteins

Figure 1: Proteoglycan Aggregate (Mironowicz et al. www.wor1dortho.com)
Because of the high weight-bearing load the articular cartilage must support,
stiffness and durability are largely important. The strength of this tissue depends on the
molecular structure and the size of the proteoglycan aggregates. As cartilage matures, a
large problem exists due to the degeneration of the tissue. The constant large weightbearing load that is placed on the knee causes a change to occur in the aggrecan
concentration. This concentration is decreased along with the length of
glycosaminoglycan chains. With this large decrease in material inside the articular
cartilage, the water content then increases causing a downward shift in the stiffness of the
tissue. This can lead to mechanical damage because the articular cartilage no longer
holds the same strength and pressure resistance as before.
Besides collagens and proteoglycans, the articular cartilage is composed of many
noncollagenous proteins. These proteins include fibronectin, thrombospondin,
chondroadherin, link protein, cartilage matrix oligomeric protein, and cartilage matrix
proteins.
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As mentioned before the chondrocytes in articular cartilage receive their
-
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nutrients from the synovial fluid inside the tissue. The tissue fluid is made up of water
with dissolved gas. Water is actually the main component of articular cartilage, making
up 60-85% of its wet weight (Hasler et al. 423). The water is present in three areas of the
cartilage: inside the chondrocytes, in the intrafibrillar space of collagen, and inside the
domain of the proteoglycans. This high fluid content is important to the articular
cartilage because the mobile cations of the water bind with the highly negative charge of
the proteoglycans to produce a swelling pressure in the cartilage. This swelling pressure
acts almost like a cushion that responds to the high stresses at the joints. The
proteoglycans play a key role within the tissue because they are the main determinate of
the swelling pressure inside the tissue, which dictates the strength, stiffness, and the
ability to withstand pressure exerted on articular cartilage.
The chondrocytes are the only cell type that reside in the composition of articular
cartilage. These cells synthesize the matrix components, organize the matrix
composition, and control the eventual degradation of these components inside the
extracellular matrix. There is no cell-to-cell communication between chondrocytes and,
as previously addressed, cartilage lacks blood and lymphatic vessels, which is why these
cells receive all nutrients via diffusion through the extracellular matrix. This means that
any change in fluid flow due to any stress or strain induced on the tissue can affect the
productivity of the chondrocytes. Changes in the chemical factors, such as taking various
medications, or the matrix coinposition can also influence the normal function of the
chondrocytes. If the cells aren't in a normal or "happy" state, degradation of the articular

5

cartilage will occur because the cells aren't synthesizing the matrix components and
properly diffusing nutrients in and out of .the tissue.

Zones and Regions of Articular Cartilage
Articular cartilage is not a homogenous tissue; instead, it has four zones that are
organized vertically which are distinctly different from one another. There are also three
matrix regions that exist in layers around the chondrocytes. The superficial zone is the
zone farthest from the actual subchondral bone. This zone is the thinnest of the four and
functions to provide a gliding surface for the end of the joint. The collagen fibrils are
arranged parallel to the articular surface. Because of the thinness of the zone, the fibrils
have a small diameter and are packed in a highly dense manner. The chondrocytes are
flat and inactive in this zone. Also, both the aggrecan content and the cell volume are
decreased, while the cell density is increased. The proteoglycans and collagens are
densely packed and closely interconnected in this zone, providing a strong structure to
reduce the stresses produced at the surface of the bone due to motion.
Below the superficial zone is the transitional zone, which has a much greater
thickness. The collagen fibrils are more loosely (randomly) arranged and have a larger
diameter. The chondrocytes resume a more normal rounded shape, which allows them to
be both larger and more active. This zone holds the highest proteoglycan content.
The radial zone lies beneath the transitional zone and is divided into two separate
areas-the

upper and lower radial zone. The collagen fibrils are loosely organized in a

perpendicular fashion with respect to the subchondral bone. They have their largest
diameter in this zone. The water content is very low in this zone and the proteoglycan
content is high. The metabolic activity of the chondrocytes is at its highest.
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The deepest zone is the calcified zone, which lies between the deep zone and the
-

-.

subchondral bone plate. There is a separation that exists between the deep zone and the
calcified zone called a tidemark. This zone is a bit stiffer than the others because the
cartilage is mineralized with crystals of calcium salts. The proteoglycan content is low
and the collagen fibrils are arranged starting from the deep zone and insert into the
calcified zone acting as an anchor for articular cartilage to be attached to the underlying
subchondral bone. This zone serves as a structural integration mechanism between the
articular cartilage and the underlying subchondral bone (Hasler et al. 426). Below, in
Figure 2, is a diagram illustrating the four zones and three regions existing in articular
cartilage.

I

Articular aurfaco

I
Pericallular
region

Radial

Territorial
region

. Interterritorial
region

zone

Ttde mark

_

Hypomphic
c hondrocyte

.

Subchondral
bone

Figure 2: Four Zones and Three Regions of Articular Cartilage (Hasler et al. 424)
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There are three matrix regions surrounding the chondrocytes. The pericellular
matrix is the layer immediately surrounding the cells. The chondron is a term that refers
to the chondrocyte and the pericellular matrix, which acts as the structural and functional
unit of the cartilage. There is a rapid rate of turnover for the matrix components in this
region due to the high presence of proteoglycans. Collagen filaments are thin in this
matrix region, ranging from 10 to 15 nrn in diameter (Hasler et al. 426). The pericellular
matrix acts as a protective barrier for the chondrocytes against the high mechanical
pressures that are exerted on this tissue.
The territorial matrix is a woven network of fine cartilage fibrils that are located
around the pericellular matrix. Within the radial zone, the territorial matrix is organized
in a way that it actually surrounds columns of chondrocytes. The chondrocytes have
cytoplasmic projections that allow them to come into contact with the collagen fibrils
located within this zone.
Lastly, the interterritorial matrix of articular cartilage is both the outermost layer
and the largest of the three in size. As the distance at which the collagen fibrils are
located is increased from the chondrocyte they surround, the collagen fibrils increase in
size. Therefore, collagen fibrils will be larger the farther away they are located from the
chondrocyte it is surrounding. The proteoglycan content is decreased in this area.
Functions of Articular Cartilage
As previously mentioned, the largest task of articular cartilage is the ability to
resist compression. The idea of cartilage swelling due to a pressure gradient is a large
contributing factor to helping with this task. There are negatively charged groups
connected to the glycosaminoglycan chains, giving cartilage a highly negative charge
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density. In the synovial fluid there are positively charged sodium and calcium ions
-
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floating around that are attracted to the GAGs, which will allow for the existence of
electroneutrality. When there is an imbalance of ions inside of the tissue that is higher
than that of the external solution, an osmotic pressure is created. The negative charges on
the GAGs produces a strong repelling force, which causes the extracellular matrix within
the articular cartilage to swell. The collagen mesh has the ability to balance the swelling
of the proteoglycans and return the tissue to its normal state. As weight is put onto the
joint, the proteoglycans are pushed out of the cartilage (the negative charge is pushed out
of the tissue as well), which increases the charge density. Both the osmotic and
interstitial fluid pressure within the matrix are now increased. The ideal situation is for
the interstitial fluid pressure to rise above the osmotic pressure, allowing the interstitial
fluid to exude and increase the proteoglycan content. The abundance of proteoglycans
leads to an increase in the repulsive forces until an equilibrium is formed that has the
ability to withstand the applied load. This is how the articular cartilage has the ability to
resist compressive forces in the joints of the body.
Articular Cartilage Limitations

As humans mature, a major problem in articular cartilage is degeneration of the
tissue. There is a limited potential to restore cartilage located at the joint surfaces. The
chondrocytes have a low level of mitotic activity and the tissue is completely avascular.

An injury to the cartilage can occur in any joint and is referred to as a lesion or defect.
The most common area of degeneration is the knee, and treatment of this joint is studied
most often because of its importance for daily human activity. There are two main

categories of articular cartilage damage: partial thickness defects and full thickness
-

defects. An illustration of the two defect types can be seen below in Figure 3
A: partial thickness defect

subchondral
bone

6: full thickness defect

Figure 3: Partial Thickness and Full Thickness Defects (Redman et al. 23)

A defect is defined as partial or full thickness according to the depth it penetrates
into the marrow spaces of the subchondral bone. Partial thickness defects are analogous
to the clefts and fissures that are seen in the early stages of osteoarthritis (Hunziker et al.
72 1). As the stages of osteoarthritis progress, the fibrillated lesions grow larger and

deeper. These lesions do not heal spontaneously. Many researchers have made the
assumption that the failure to regenerate is due to the fact that the defect does not
penetrate the subchondrol bone (bone marrow); therefore, there is no access to the
progenitor cells in the bone marrow space. In opposition to this idea, it has been proven
that spontaneous repair of a superficial defect does occur with no fibrous scar and
restoration of the zonal organization of articular cartilage. Whether or not this repair is
"true" repair or void filling is still a question that remains unanswered (Redman et al. 23).
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Often, in mature cartilage, a limited amount of repair does occur within the tissue
immediately adjacent to the site of the lesion. This process begins with the occurrence of
cell death in the areas adjacent to the wound. After twenty-four hours have passed an
increase in cell proliferation and matrix synthesis at this area occurs, but it is short lived
and there is no actual repair of the defect. Growth factors signals additionally make an
attempt to heal the defect by inducing cells to migrate across the articular surface from
the synovium to the lesion, but again fail to do so due to the anti-adhesive properties of
the proteoglycans (Redman et al. 23). These processes suggest it is not just the absence
of bone marrow cells that causes incomplete healing of partial thickness defects; instead,
there are other mechanisms involved that play a role in the inability of the partial
thickness defects to heal correctly.
Full thickness defects fully penetrate the subchondral bone and are able to access
the cells in the bone marrow. The repair response that occurs due to this defect results in
the formation of a fibrocartilaginous tissue at the site of the defect. In most cases, once
the subchondral bone is penetrated by the in a full thickness defect, there is immediate
formation of a hyaline-like articular cartilage. This tissue is an undesirable replacement
for cartilage and degeneration of both the repair tissue and the native tissue occurs. It has
been noted in some cases that during this process, the tissue adjacent to the wound
becomes necrotic and almost no remodeling occurs (Redman et al. 24). Upon
examination of the full thickness tissue defect, there were many areas of continuity as the
tissue changed from native to repair tissue, but no true integration was present. Because
the outcome of both partial and full thickness defects have a lifelong negative effect on
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the joints, there is a great challenge for tissue engineers to discover a successful way to
heal articular cartilage defects.
Osteoarthritis is the number one disease causing articular cartilage damage for
adults. Avascular necrosis is another condition that can increase the risk of articular
cartilage degeneration. This disorder involves the death of the bone tissue that lies
beneath the cartilage as a result of insufficient blood supply. Also, osteochondritis
dissecans is a condition when the blood supply to a discrete area of the bone is disrupted
and there is brealung away of fragments of bone and cartilage in the knee. Traumatic
injury due to sports or accidents of any type can also cause articular cartilage injury.
Lastly, inflammatory disease, such as rheumatoid arthritis can cause articular damage.
Current Methods For Treating Articular Cartilage
There are many methods currently available that attempt to both heal and initiate
the regeneration of articular cartilage. For minor articular cartilage defects, the abrasion
technique is utilized to try and rid a small area of loose cartilage pieces. A technique
called arthroscopy is used, which is when an incision is made at the site of the injury and
both fiber optics and small instruments are used to clean out any loose particles located in
the joint. Bleeding is also induced at the bone surface at the site of the wound.
Fibrocartilage growth is then induced at that area as the body attempts to heal itself at the
site. The positive aspect of this procedure is that it is brief and does not require the
patient to be hospitalized. The negative aspect of the procedure is that it does not have a
very high success rate since the fibrocartilage that is produced at the area of the defect
may not fully fill the gap and become a durable tissue replacement. Fibrocartilage will
never be able to function in the same way as native articular cartilage.
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The next treatment option available for damaged articular cartilage is
microfracture, which is highly similar to the abrasion method, but with an added step.
Debridement, which is the act of provoking bleeding, is done at the site of the wound.
Fibrocartilage is formed, but in addition to clearing away the damaged area, the surgeon
uses a sharp instrument to make perforations in the bone. The bone marrow contains
pluripotent cells that have the ability to differentiate into cartilage in t h s technique, under
the influence of motion. A continuous passive motion (CPM) machine is often utilized
by the patient, which allows the knee to repeatedly follow a circular range of motion
without putting any pressure on the joint. This machine is used following the operation
for several hours a day. The positive aspect of microfracture is the cheap cost and simple
procedural steps. Microfracture serves as the best treatment for well-contained lesions
(Novick Cartilage Regeneration-An Overview). Once again the ability for the
fibrocartilage to fill the entire gap is questionable and the patient must refrain from
placing weight on the affected joint for a specified period of time. If fibrocartilage is
formed at the affected area, the durability of the new tissue will not be that of the native
tissue.
Mosaicplasty is a highly talked about technique, which is also referred to as
osteochondral autograft transplantation (OATS). Both fresh and cadaveric donors are
used for this method, but research has shown that the fresh tissue is more successful in
terms of preventing cell death and the ability to achieve mechanical stability (Redman et
al. 25). Osteochondral transfer is a repair method that is used in the same way as the
periosteum and perichondriurn grafts that will next be described, but in the next method
both allogenic and autogenic grafts are used to repair the defective tissue area.
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Autologous ostechondral grafts involve the removal of plugs of osteochondral tissue
from a low weight bearing area in the body that is transferred to the debrided defective
area. Depending on the size of the damaged area, one plug or multiple plugs are utilized.
This method is usually chosen for small to medium size defects because the larger the
defect, the larger the risk for rejection (immunologic response). This method is also
better for patients under the age of 45 with stable joint mechanical alignment (Boland,
Arthur et al.). An advantage of this techmque is the high survival rate of the
chondrocytes and the ability of the plugs to maintain the original hyaline cartilage
characteristics. The disadvantages are morbidity at the site where the plugs are removed,
the limited supply of tissue available to use as plugs (must be located at a low weight
bearing area), and the long rehabilitation time that is required (Boland, Arthur et al.).
Also, it is hard to find any area in the joint that is not bearing any weight, so the smaller
the defect this technique is used for, the better. There is possibility of chondrocyte death
around the edges of the plugs that have been implanted, which causes a space to form
between the graft and the native surrounding tissue. This discontinuity can lead to
degeneration of the graft over time if cartilaginous tissue (or fibrocartilage) is not formed
to fill in the gaps. Multiple studies have showed that patients undergoing this treatment
do show a decrease in pain and an improvement in joint function.
A technique that is fairly simple and not often used is the removal of a piece of
the periosteum or perichondnum, which is the connective tissue that covers all bones,
from a low weight bearing area on the shin. The periosteum/perichondrium is then
transplanted into the site of the defect. The idea is that there are pluripotent cells located
in this tissue that lead to cartilage regeneration. T h s method is used to repair full
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thickness defects. In experimental trials, a defect is created at the damaged site that is
-

- .

four mm in diameter. One to two mm of thickness of subchondral bone is removed to
make room for the insertion of the healthy tissue. The periosteal or perichondrial graft is
then implanted into the defective cartilage and fibrin glue is used for adhesion. When
this method was used in a rabbit study, 33% of the cases showed the formation of repair
tissue that was derived solely from the transplanted periosteum. The other 67% had
repair tissue that was derived from both the transplanted tissue and the bone marrow
mesenchymal stem cells (Redrnan et al. 25). Continuous passive motion (CPM) is an
important factor in the successful healing of the damaged joint when utilizing this
technique. This procedure does require an overnight visit to the hospital and the result
can be one of mixed normal and fibrous tissue at the damaged site.

A highly popular method for natural regeneration of articular cartilage is
autologous chondrocyte implantation (ACI). Chondrocytes are taken from a healthy area
of the knee that is not involved in the injury and are implanted at the area of damage.
Chondrocyte precursor cells from the grafted periosteum and mesenchymal stem cells
derived from the subchondral bone marrow space are cell sources that can also be
utilized. The cells are cultured for approximately 14-21 days and then injected into the
affected area. The entire area is then covered with a sutured periosteal flap that is taken
from the proximal medial tibia. Brittberg et al. performed a study that involved 16
patients that were treated with ACI at the femoral joint and seven at the patellar joint and
followed them for a mean of 39 months. The transplants initially eliminated pain,
swelling, and locking of the knee for all patients. At the three month mark, all of the
patients showed that the transplant area was level with the surrounding healthy tissue.
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The tissue also appeared to have the same spongy (resistant) characteristics as the
healthy surrounding tissue. After two years, 14 of the 16 femoral ACI patients had good
to excellent results. The other two patients had to undergo a second operation. The
results in the patients that underwent patellar ACI were good to excellent in only two of
the seven patients, fair for three, and poor for two. The two that were rated as poor
underwent a second operation. There were signs of hyaline cartilage in one of the seven
patellar ACI patients and eleven of the sixteen femoral ACI patients (Brittberg et al. 892).
The major advantage of this technique is the possibility of normal hyaline cartilage
restoration. The disadvantages include the high price, requirement of two separate
procedures (cell insertion and the adhesion of the flap to cover affected site), and the
unpredictability of the results for the operation. It has been proven that implanted
chondrocytes do have the ability to participate in the formation of repair tissue denoted
by the formation of type I1 collagen and can persist in helping to heal the defect for up to
14 weeks.
A method that is a continuation of ACI is the use of a specific chondrocyte
population taken from an identified area within the articular cartilage that may have
better replication and integration characteristics in comparison to chondrocytes taken
from another area. Waldman et al. performed a study which took cells from the full
thickness, mid and deep zone, and deep zone of articular cartilage. The cells were seeded
onto calcium phosphate substrates and cultured in vitro. The full thickness chondrocytes
showed the highest amount of collagen synthesis, but the mid and deep zone
chondrocytes showed the best mechanical properties and accumulation of proteoglycans.

If the cells from the mid and deep zone were used to as the implanted cells for ACI,
-

- .

there would be an improved rate of articular cartilage tissue repair (Redman 28).
Another method in repairing articular cartilage is the use of a tissue engineered
scaffold as a tissue substitute to treat the damaged cartilage. When chondrocytes are
implanted without a scaffold (such as in the ACI technique), they only have the ability to
synthesize their native ECM proteins, but when the cells are first cultured onto an actual
scaffold and implanted, the proteins are deposited within the engineered matrix and thus
have the ability to organize and remodel this structure. When only a cell culture method
is used, the ECM proteins will just diffuse out into the culture media. The major
requirements the engineered scaffold must meet are structural integrity, biocompatibility,
and the correct mechanical stability. The scaffold must be strong enough to support the
high loads that are placed on the knee and be porous enough to allow synovial fluid to
flow in and out of the matrix for proper infiltration of the structural molecules. There are
two major scaffold types: those made from synthetic materials such as polymers and
those made from natural materials. There are positives and negatives to choosing either
scaffold material. Scaffolds are three-dimensional and can be formed into a desired
shape depending on the method of its construction.
Two highly popular synthetic materials used to create a three-dimensional
scaffold for the replacement of articular cartilage are poly(glyco1ic acid) (PGA) and
poly(1actic acid) (PLA) polymers. Tissue engineers often use the materials individually
or combine them into various combinations such as a copolymer made up of 50% PLA
and 5O%PGA to form a scaffold that mimics their mechanical requirements. These
scaffolds are naturally biodegradable and, depending on the method used for the
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fabrication of the construct, pore size and the fiber diameter can be manipulated.
-

-

Polymer scaffolds have been shown to equally promote proteoglycan regeneration and
chondrocyte proliferation, differentiation and maturation in comparison to collagen-based
scaffolds (Grande et al. 2 13). When utilizing synthetic scaffolds, the need for any donor
tissue is eliminated and the shape of the scaffold can be coinpletely formed to perfectly
fit the defective site. The downfall is the risk of rejection from the body.
There are various methods used to create the synthetic scaffolds for articular
cartilage replacement. Freed et al. had Acufex Inc. form PGA scaffolds that contained
12-14 pm diameter fibers forming a non-woven mesh that is 0.1 to 0.2 cin thick with a
bulk density of 55-65 mg/cm3. The mesh was then cut into 1 cm diameter discs that were
sterilized and seeded with cells. Freed et al. found that chondrocytes were able to
proliferate on the PGA scaffold and regeneration of the cartilaginous matrix occurred.
This study also compared the difference between seeding ,the scaffolds with primary
chondrocytes, unpassaged chondrocytes and passaged chondrocytes. Defects that were
filled with all three cell types did have signs of a white colored repair tissue (similar to
the blush white appearance of native articular cartilage) after one month of in vitro
implantation. The passaged chondrocytes showed 1.7 times as much GAG production
and 2.6 times as much collagen production when compared to the scaffolds seeded with
primary chondrocytes (Freed et al. 891).
Grande et al. compared the pros and cons of using synthetic and natural scaffolds
to create tissue engineered articular cartilage. They used PGA to make two min thick
non-woven fiber mats with a pore size of 200 pm; a PGA-PLA copolymer to make a flat
woven mesh mat with 2 10 pm pores; and nylon to make flat, square, knitted mesh with
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90 pm pores. A comparison of the rates of synthesis of proteoglycans and collagen
were examined for all of the scaffold types. Also, whether or not a bioreactor closed loop
recirculation system could increase the synthesis of molecular proteins was studied.
There was a greater rate of proteoglycan synthesis on the polymer scaffolds compared to
collagen production. The use of the closed loop bioreactor system increased synthesis of
all molecular proteins for all three scaffolds in con~parisonto its absence. This increase
only occurred initially and did not sustain a difference over a time period of three weeks
(Grande et al. 21 1). Nylon was the least efficient of the three polymer types. For the
PLA-PGA blend, the chondrocytes easily attached and replicated in the scaffold, but did
not transverse into the large pores. Grande et al. stated that when chondrocytes have a
spindle shape they are not as happy on the scaffold as when they have a spherical
morphology. For all three polymer scaffolds the cells had a spindle shape, which
indicates they were not perfectly "happy."
Grande et al. also compared these three polymer scaffolds to a collagen type I
bovine fibrillar matrix with a two mm thickness and pore size ranging from 200 to 300
microns that were also seeded with chondrocytes. The proteoglycan synthesis was
limited compared to PGA for this scaffold, but the collagen production was higher than
that of the polymer scaffolds. The cells on the natural scaffold showed a spherical
morphology, suggesting the scaffold could induce the proper gross phenotypic
characteristics in the cells, allowing them to attain their natural shape. Grande et al.
discovered that the proteoglycan synthesis increased at a continuous rate when the
collagen type I scaffold was cultured in a closed culture system at all the time points
under observation.
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In 1997, Nehrer et al. compared sponge-like scaffolds made from type I and
type I1 collagen for the synthesis of chondrocytes. The type I collagen scaffold was
constructed from bovine hide using an acetic acid extraction followed by freeze-drying to
form a porous membrane. The type I1 collagen scaffold was produced by treating porcine
cartilage to form a three-dimensional sponge-like material with pores that were
interconnected. The type I1 sponges underwent UV irradiation to cross-link and allow for
an increase in strength. Both matrices were seeded with chondrocytes in vitro for three
hours, seven days, and fourteen days. There was a higher percentage of chondrocytes
with a normal spherical shape for the type I1 matrix at all three time periods. The GAG
and DNA content increased for all three time points in a larger amount for the type I1
collagen scaffold compared to the type I collagen scaffold. The type I1 matrix allowed
for a better site for chondrocyte implantation because it had a higher percentage of
spherical chondrocytes and there was greater molecular activity for this scaffold as was
illustrated by the increased rate of GAG and DNA production. This assumption was
reaffirmed by Pieper et al. in 2001 and Gigante et al. in 2003.
Pieper et al. followed in Nehrer et al.'s footsteps and compared collagen type I
and type I1 scaffolds as a site for the implantation of chondrocytes. At first, both the
bovine Achilles tendon to make the type I scaffold and the bovine tracheal cartilage to
make the type I1 scaffold underwent an acetic acid extraction. The type I1 collagen did
not swell properly in the acetic acid; therefore, a pepsin digestion method was utilized.
Porous type I and type I1 collagen matrices were produced via freezing and
lyophilization. Pieper et al. also treated some of both scaffolds types with chondroitin
sulfate to see if cell integration was improved. The matrices were cross-linked and the
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chondrocytes were seeded in vitro. The matrices were evaluated according to the
.

--.

ability of the chondrocytes to proliferate and differentiate. The type I1 collagen scaffold
provided a better distribution of cells throughout the matrix. Both the type I and type I1
collagen scaffolds did show a cartilaginous-like layer at the surface and the presence of
chondrocytes throughout the matrix. The type I1 collagen showed an increase in these
characteristics in comparison to the type I scaffold, but the addition of chondroitin sulfate
had no affect on the scaffold quality (Pieper et al. 3 191).
After both Nehrer et al. and Pieper et al., Gigante et al. compared scaffolds made
from type I and type I1 collagen for use as a cartilage replacement. The type I collagen
scaffold was made from equine tendons that were put through an acid extraction process.
After stringent purification techniques were performed and the acetic acid was removed,
the material was lyophilized and formed as films in dies that were contained in an
electrostatic field. The collagen type I1 scaffold was made from porcine samples that
were processed the same exact way as those made from the equine tendon, except HC1
was used for the acid extraction instead of acetic acid. The scaffolds were seeded with
chondrocytes and the cell morphology was studied in order to decide which scaffold
allowed for a conducive environment. On the type I collagen matrix, the cells held an
elongated shape and formed a layer of only one to two cells thick on the membrane
surface. The cells on the collagen type I1 matrix were spherical in shape that were
several cells thick on both the membrane surface and penetrating through the scaffold
(Gigante et al. 714).
The latest technology that is under investigation is the use of stem cells that are
derived from tissue sources other than articular cartilage. Stem cells have the ability to
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self-renew and morphologically change according the environment into which they are
implanted. Stem cells will spark both regeneration and repair in a desirable manner that
is required by the tissue at the site they are implanted when damage occurs.
Mesenchymal stem cells taken from bone marrow are currently being considered. These
cells can then be used in the ACI method previously described or grown on a scaffold and
inserted into the body.
Overall, the use of a scaffold, whether natural or synthetic, has proven to give the
best results when implanted into the body to encourage cartilage regeneration. If the
scaffold is composed of collagen type 11, which is the material making up the majority of
the articular cartilage tissue, a high degree of reproducibility is not guaranteed, but has
shown better results in comparison to scaffolds made from type I collagen. Polymers are
usually manufactured with h g h reproducibility and can be molded into nearly any shape.
The degradation rate of the polymer can be easily controlled, but this scaffold type has an
increased risk of rejection from the body. It is common sense to assume that the body
would be more accepting of a natural material. The cells would more easily adapt and
regenerate in its natural environment. A blend of natural and synthetic materials to make
a scaffold would be potentially advantageous because the body would easily accept the
scaffold because of the natural material, but the polymer material would increase the
strength, integrity, and reproducibility of the scaffold. An improvement for the actual
construction method of the scaffold is the major area that needs improvement.
Electrospinning Background
Electrospinning is a method of creating a micro to nano-fibrous non-woven mat
that was first utilized in 1934 by Anton Formhals (Forrnhals 1) who was granted a patent

to use this idea to spin a cellulose ester solution. Next, William Huebner (Huebner 1)
-

received a patent that allowed him to utilize the method of electrospinningto spin sheets
or webs. Both patents utilized this technology to form continuous sheets of material for
commercial use.

A high voltage power supply, ground and source electrodes, a dissolved solution
to be spun, and a grounded collection surface are the required equipment for
electrospinning. The electrospinning system requires a charged solution that can be
either a natural or synthetic material that is dissolved in a solvent. Electrospinning
requires that a fluid jet be subjected to a highly charged electric field with little or no
current present. The jet is drawn out of the syringe at a set speed, which is dependant
upon the material that is being electrospun. As the fluid jet leaves the needle tip, the
solvent evaporates and a dry single fiber is formed that whips around in the air between
the needle tip and the collecting plate (mandrel). A grounded surface, referred to as a
mandrel, is located at a distance from the charged solvent creating an electric field. The
fibers wrap around this surface to from a porous sheet of fibers. The shape and size of the
collection plate is completely dependant on the desired use of the mat. A diagram of the
electrospinning process can be seen below in Figure 4.

.

Collutlon T m e t
E l m r l c Field

Figure 4: Diagram of Electrospinning Apparatus
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Collagen Type 11 Extraction

- .

Type I1 collagen is the main constituent that makes up cartilage ECM, so this
material was chosen for use in this experiment. There are various sources that can be
used to extract type I1 collagen. Pieper et al. extracted type 11 collagen from bovine
tracheal cartilage via pepsin digestion. Various dialyses were performed on the material
to assure purity and the final form of the material was reached after lyophilization.
Herbage et al. used the same extraction method but instead of using bovine tracheal
cartilage, bovine patellar articular cartilage was used. Gigante et al. extracted type I1
collagen from porcine trachea using HCl for the extraction procedure. Films were then
formed in dies from this material with the use of electrostatic charge. Nehrer et al. also
extracted type 11 collagen from porcine cartilage, but the end product was a sponge-like
material with the use of lyophilization. Three groups of researchers: Edward Miller,
Trentham et al. and Von Der Mark et al. utilized chick cartilage to extract type I1
collagen. A SDS-Page was used to identi@the level of purity of the type I1 collagen and
to check for any type I collagen contamination. Because bovine samples are the most
readily available, this was the material utilized for the extraction process in our
experiment. The largest amount of type I1 collagen is found in the patellas of bovine
specimens in comparison to other test animals including rats, chicks, or porcine
specimens. The age of the cartilage chips that will yield the greatest amount of material
is also in question. Our study compared the type 11collagen found in fetal cartilage chips
and two groups of patellas from bovine samples that are 140-180 days old.
The electrospinning of type I1 collagen is novel, and will produce a material that
has fibers which resemble that of the native tissue fibers. The material will be natural
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and completely composed of type I1 collagen, which makes up 90% of the total
collagen content in cartilage. This material should be easily accepted by the body
without the risk of rejection and can be formed into any shape for implantation. The
yield of the extraction for the three groups of cartilage chips will be examined along with
the characteristics of the electrospun scaffolds.

Materials and Methods

This project was undertaken to discover the different end amounts of type I1
collagen that can be extracted from the cartilage chips of different age bovine specimens.
It will also be determined whether or not the purity of the end product of collagen type I1
is affected according to whether or not there are remnants of blood vessels or bone
marrow present in the chips. If the extraction of collagen type I1 from the cartilage chips
is successful, it is desirable to discover if collagen type I1 can be electrospun into
scaffolds that have the ability to be tailored to the use of interest. The properties of the
electrospun scaffolds should be evaluated according to pore size and fiber diameter at the
concentrations of 0.06,0.08,0.10, and 0.12 g collagen type I1 /mL HFP for the three
bovine groups.
The protocol utilized for the collagen type I1 extraction was donated by Dr. David
Brand. He also donated the fetal cartilage chips for the study. The cartilage from all of
the fetal bovine joints were utilized for the extraction of the type I1 collagen. Cartilage
chips were purchased from Lampire Biologics (Pipersville, PA), which contained
fragments of bone marrow and blood vessels. The age of the cows utilized for these
chips was 140-180 days old and only the patellar joint was utilized. Whole patellas were
purchased from Spear Products (Quakertown, PA) within the same age groups as the
chips from Spear Products. The articular cartilage was manually scraped from .the Spear
Products patellar surfaces with the use of a scalpel. Only the clear hyaline surface was
25
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used to create the chps, leaving no blood vessel or marrow contamination when the
- -.

type I1 collagen was extracted. The following section describes the steps followed to
extract collagen type I1 from the cartilage groups.
Extraction of Type II Collagen
1. Cartilage chips from the ends of all joints of fetal bovine specimens were obtained
from Dr. David Brand. Bluntly pre-cut cartilage chips from bovine patellas were
obtained from Larnpire Biologics that were slightly contaminated with fragments
of bone marrow and blood vessels (140-180 days old). Whole patellas from
calves (140- 180 days old) were obtained from Spear Products and the hyaline
cartilage surface was scraped off creating cartilage chips with no contamination
(completely clean chips). Below is a picture of each of the three cartilage chlp
groups used for the experiment.

I.

Figure 5: Lampire Cartilage Chips

Figure 6: Spear Cartilage Chips

Figure 7: Fetal Cartilage Chips
2. The weight of the cartilage chps was obtained for each batch, and the chips were
cut into smaller pieces with a razor blade. The cutting tray was set over a bucket
filled with ice in order to keep the cartilage from reaching a temperature over 4°C.
A Waring CB15 three horsepower blender was used to blend the chips with
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deionized water (Barnstead International combination organic
removal/ultrapure filter #D8922) and ice to macerate them into the smallest size
possible. For every 100 grams of material that was put into the blender, a
combination of approximately one liter of ice (equal to 500 mL of water) and 500
mL of deionized water was added. The blender underwent three pulses at the
maximum setting for the duration of one minute each. Between each pulse, the
lid was removed and the material was wiped down from the sides to assure all the
material was blended.
3. A volume of cold (4°C) 5 M guanidine (Sigma Aldrich #G4505) that was made to

have a pH of 7.4 with the addition of 0.05 M Tris (VWR buffer Tris pH 7.50
#VWR873 1-1) was added in an equal volume amount to the blended mixture.
The guanidine removed the proteoglycans. For example, if the batch were 100
grams, one liter of ice and 500 mL of deionized water would be added to the
blender. The guanidine solution, with a pH of 7.4, would be added to this
solution in the amount of 750 mL. The addition of these solutions to the blended
cartilage pieces was done in a seven liter bucket (Nalgene #7012-0800) for a
starting solution that was smaller than two liters or a 13 liter bucket (Nalgene
#7012-0140) for a starting solution that was over two liters. The bucket sat on a
stirring plate (Corning heavy duty stirrer #PC-61 1) with a magnetic stir bar (VWR
polygon magnetic stir bar 70 mm x 10 mm #VW873 1-1) at the bottom of the
bucket stirring at the setting of seven. The solution was then placed in a
refrigerator (4°C) or cold room (4°C) to stir overnight.
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4. The mixture was then put into a Beckman Coulter Avanti J-20 XP centrifuge
-

- .

(JLA 8.100 rotor, 6 slots with a volume of 1000 mL each, 20" angle) at 8336 g
(6000 RPM) for 30 minutes. The centrifuge was set to a temperature of 4°C. The
supernatant was discarded and the deionized water was added to the cartilage
pellet in a volume equal to the starting volume from step #2 (1500 mL for the
example explained in step #3). The cartilage chips and deionized water stirred in
the cold room for one hour to wash the pellet. The addition of the deionized
water to the cartilage and the stirring of the material were done in the same
manner as the stirring set up that was described in step #3.
5. The cartilage pellet was then again centrifuged in the Beckman Coulter Avanti J20 XP centrifuge at 8336 g at 4°C for 30 minutes. The pellet was washed and
centrifuged a minimum of three times. The reason for so many repeated washings
of the pellet was to assure all of the guanidine was completely removed before
moving on to the next step.
6. After the last wash was completed, the pellet was suspended in a volume of 0.5 M
acetic acid (HAc) (Fisher Scientific #UN2789) that was equal to the amount of
deionized water that was added for washing the pellet (1500 mL for the example
batch). Thls was done by removing the pellet from the centrifuge tubes with a
spatula and adding it to the 0.5 M HAc and stirring the solution in a manner
identical to that described in step #3. The pH of the stirring solution was then
adjusted to 2.8 with the addition of formic acid (Sigma Aldrich #F0507).
7. Pepsin (Sigma Aldrich #P-6887) was then added to the solution in an amount of
one gram per one liter of solution. The needed amount pepsin was first dissolved
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in a small amount of cold distilled 0.5 M HAc (approximately 3 mL 0.5 M HAc
-

- .

per gram of pepsin). This was then immediately added to the stirring (stirring setup described in step #3) cartilage homogenate. If the pepsin solution was not
added quickly, it would autolyze in the acetic acid solution.
8. The solution was then mixed with tall electric stirrer that entered into the liquid
from the top of the bucket (Arrow Engineering Company, Inc #850) via a ring
stand (Caframo #A210) that could be adjusted according to the height of the
bucket at 4OC in the cold room or refrigerator overnight. The homogenate was
viscous with minimal cartilage pieces the within 24 hours.
9. The homogenate was then centrifuged in a Beckman Coulter Avanti J-20 XP at

8336 g for 60 minutes at 4OC. The supernatant then contained the solubilized
type I1 collagen and the pellet could either be discarded or another pepsin
extraction could have been performed at this point.
10. Ten milliliters of 1 M Tris was added for every liter of supernatant collected. The
was then brought to 7.4 with the use of 10 M NaOH (VWR
pH of the sol~~tion
#VW3247-I). An equal volume of 5 M NaCl (Fisher Scientific #S640-500) was
then added to the solution at a very slow rate while the solution was constantly
stirred. The addition of both the 10 M NaOH and the 5 M NaCl was done while
the solution stirred in the manner described above in step #3. The solution was
then left out at room temperature for 24 hours. A cloudiness was observed in the
solution after the 24 hours passed.
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11. The collagen precipitate was then collected by centrifugation in the Beckman
Coulter Avanti 5-20 XP at 8336 g for 60 minutes at 4OC. The pellet was collected
and the supernatant was discarded.
12. The pellet was put into a solution of 0.05 M Tris that was equal to the beginning
volume from step #2 (water and ice volume combined). 0.2 M NaCl was then
added to adjust the pH to 7.4. The pellet was dissolved (stirred as described in
step #3) in this solution for 24 hours at 4°C in the cold room or refrigerator. A
dialysis (dialysis membrane tubing, MWCO 12,000 to 14,000 Daltons, Fisher
Scientific #08-667E) was then performed on the material against the same buffer
the pellet was dissolved in for two total changes, once every 24 hours, at 10 times
its volume. The dialysis tubing utilized had a flat width of 45 mm, diameter of 29
mm, and a volume/length of 6.4 mL/cm. The tubing was cut into lengths of two
feet and filled with the material and knotted at the ends. A maximum of three
tubes were placed in each of the 13 liter buckets.
13. The dialyzed material was centrifuged in the Avanti 5-20 XP at 8336 g for 60
minutes. The supernatant was collected and the pellet was discarded.
14. 500 g of DE 52 (Whatman #4057200) was added to the supernatant and was
stirred (described in step #3) at 4OC for 24 hours.
15. The solution was centrifuged in the Avanti J-20 XP at 8336 g for 30 minutes at
4"C, and the supernatant was kept.
16. The correct volume of 5 M NaCl was added to the supernatant to make the
solution have a final concentration of 0.8 M NaC1. Also, the correct volume of
HAc was added to the solution to make the final concentration 0.1 M HAc. The

solution was then stirred (described in step #3) at 4°C for 24 hours to
precipitate the collagen.
17. The solution was centrifuged in the Avanti 5-20 XP at 8336 g for 60 minutes at
4°C and the supernatant was discarded.
18. The collagen pellet was then dissolved in a volume of 0.1 M acetic acid that was
equal to the original volume in step #2. The solution was stirred (described in
step #3) at 4°C for 24 hours.
19. The solution was centrifuged in the Avanti 5-20 XP at 8336 g for 60 minutes at
4°C and the supernatant was collected. The supernatant was then placed in
dialysis tubing (Fisher Scientific #08-667E) and dialyzed against 0.01 M
Na2HP04 (Sigma Aldrich #S-9638) at a volume of ten times that of the solution in
the tubing (described in step # 12). The dialysis stirred (described in step #3) at
4°C and the buffer was changed a total of four times (once every 24 hours). The
collagen precipitated in this step.
20. The solution was centrifuged in the Avanti 5-20 XP at 8336 g for 60 minutes at
4°C the pellet was dissolved (discard the supernatant) in a volume of 0.1 M HAc
that equal to the volume used in step #18. The solution was stirred (described in
step #3) at 4°C for 24 hours to assure that the pellet was completely dissolved.
2 1. The solution was centrifuged in the Avanti 5-20 XP at 8336 g for 60 minutes at
4°C and the supernatait was collected. The supernatant was then placed in
dialysis tubing (described in step #12) and dialyzed against 0.01 M HAc at a
volume of ten times that of the solution in the tubing. The dialysis was stirred
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(described in step #3) at 4OC and the buffer was changed a minimum of six
-

-

times (once every 24 hours).
22. This material was then taken out of the dialysis tubing and poured into a
traditional ice cube trays (16 cubes per tray with the dimensions of 4 cm x 3 cm x
3 cm) and frozen in a Forrna Scientific -20°C freezer for 24 hours.
23. The frozen cubes were then put into 200 mL lyophilization jars, at a maximum of
four cubes per jar, and the material was lyophilized using a Labconco Freezone
4.5 freeze drying machine until it reached a fluffj white cotton ball consistency.
24. This freeze dried material was weighed and stored at -20°C
25. The end weight of the lyophilized type I1 collagen for all three groups was then
compared to the beginning weight of the cartilage chips in order to calculate the
actual yield.

SDS Page of Type I1 Collagen to Check for Purity
Once the collagen was extracted for the three cartilage chip groups, a purity test is
required to assure the end product is actually clean collagen type I1 without other
contaminants. A SDS-Page was chosen to check the quality of the extracted material
against a collagen type I and type I1 standard that was obtained from Dr. David Brand.
The following steps describe the protocol that was utilized.
1. To check for purity, the extracted collagen type I1 was dissolved at a
concentration of four pg/yL in 0.01 HAc. A 10% Pierce Endogen 12 well gel
was utilized (Pierce Endogen product # 2522 1) for the following procedure.
2. Twenty microliters of the dissolved collagen solution was placed into a 1.5 mL
microcentrifuge tube (Fisher Scientific #05-406-16). An equal part of the
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denaturing buffer was added. The buffer chosen was composed of 50 yL of P
mercaptoethanol (BME) (BioRad # 161-0710) and 950 yL Laemmli sample buffer
(BioRad product # 161-0737).
3. Step #2 was repeated for both the collagen type I and type I1 standard that had the
same concentration of four ygipL.
4. All samples were then boiled for five minutes on a Thermolyne Nuova I1 stir plate
at a heat setting of 10.
5. All samples were placed in a microcentrifbge (Fisher Scientific Micro 16) at 100
g for five minutes.
6. The gel was then placed in the gel holder (BioRad Mini-Protean I1 Cell model)
and properly aligned by loosening all the screws and assuring the gel was in
place. The screws were tightened and this set-up was referred to as a rig. Two
gels must be run at once, forming an inner chamber between the two.
7. The rig is then placed into the bucket and the inner chamber of the rig was filled
with running buffer, which is composed of one packet of BupH Tris-HEPES-SDS
running buffer (BioRad #161-0790) dissolved in 500 mL of distilled water. It is
important that there were no leaks present.
8. Each well in the gel was then flushed with a 20 pL of the running buffer. A long
0.1 to 10 yL long reach pipette tip (VWR #82028-534) was used to push the
buffer into each well and then to remove the buffer.
9. The outside of the chamber (area between the outer rig area and the bucket) was

then filled with the running buffer at a height of approximately two inches.
10. The samples were loaded into each well at a volume of 40 yL.

11. The correct lid was placed on the SDS-gel apparatus (BioRad Mini Proten I1
Cell model) and the gel was run at an amplitude of 230 and a voltage of 140
(BioRad power supply 10001500 model). The gel was nln until the dye ran off of
the plate, which took approximately 60 minutes.
12. The gel was then taken off of the gel plate and the teeth of the wells where the
material was pipetted into the gel was removed in order to form a perfect
rectangular gel.
13. The gel was then placed in a box with the dimensions of 22.5 cm x 22.5 cm x 5
cm (Nalgene #5705-2020) allowing it to be covered with coomassie blue (BioRad
# 161-0435) and shaken on an orbital shaker for one hour.

14. The gel was then rinsed with water multiple times in a highly gentle fashion or the
gel will tear.
15. The gel shook in deionized water for a few hours up to 24 hours. The gel was
stored in this fashion until an image was taken of the gel.
16. A picture was taken of the gel within two days using a BioRad Gel Doc 2000.
17. The extracted type I1 collagen from the three groups was compared to the
collagen type I and type I1 standards. This allowed for the discovery of any type I
collagen contamination and for the comparison between the type I1 standard and
the extracted type I1 collagen banding pattern.
Electrospinning of Type LI Collagen

Once the extracted type I1 collagen was proven to have a desirable level of purity,
the material was electrospun into scaffolds from solutions with the desired concentrations
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of 0.06, 0.08, 0.10, and 0.12 g h L HFP. The following steps describe the procedure
that was followed when forming the various scaffolds.
1. If there was no collagen type I contamination and the collagen type I1 standard
matched the extracted type I1 collagen banding pattern, the lyophilized extracted
type I1 collagen was then dissolved in HFP ( 1,1,1,3,3,3, hexafluoro-2-propanol
Sigma # 105228) at the concentrations of 0.06,0.08, 0.10, and 0.12 g/mL HFP.
Because the process during the first collagen type I1 extraction had many errors,
the yields of the groups were very small. The concentrations utilized to
electrospin the extracted material from the three groups was quite different. For
this group, the fetal cartilage chip group was electrospun at the concentrations of
0.05, 0.06, 0.07, 0.08, 0.09,0.10, 0.1 1,0.12,0.13, 0.14, and 0.15 g/mL HFP; the
Spear material was spun at 0.04 and 0.06 g/mL HFP; and the Lampire group was
spun at 0.08, 0.10, and 0.12 g/mL HFP.
2. The SEM pellet was utilized as the grounded mandrel. The pellet was taped onto
a rectangular (3 cm x 1 cm) mandrel that was set at a distance of 3.5 in. from the
needle tip. The RPM at which the mandrel spun was approximately 800 and the
applied voltage was 20 kV with minimal current present. The viscosity and
appearance of the solution should be noted.
3. The dissolving of the collagen type I1 into the HFP at the proper concentration
was done in a vial (VWR # 15-425). The solution was drawn out of the vial with a
five inL syringe (Becton Dikinson #309603) and a blunt needle tip (Becton
Dikinson 18 guage 1.5 short bevel #305 199) was attached to the end of the
syringe.

4. The syringe with the needle tip was then placed on a syringe pump (KD
-

Scientific #loo) that was set to dispense the fluid at the speed of 2 mL/hr and a
banana clip attached to the 20 kV power source (Spellman #CZEOPNl 00) was
connected to the needle tip.
5. The solution was then drawn out of the syringe as a single fiber that collected

onto the grounded spinning mandrel1SEM pellet. Below is a picture of the actual
apparatus that was used for this experiment.

6. The SEM pellet was removed from the mandrel and kept in order to take SEMs of

the material.

7. The SEM pellets were dry gold coated with a sputter coater from Electron
Microscopy Sciences.
8. SEMs were taken of each of these scaffolds at the four concentrations (or more
for the first extraction) for the three different patella groups using a Joel 820
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Scanning Electron Microscope (Jeol LTD, Tokyo, Japan) at a magnification
ranging from 500X to 4000X.
9. ImageTool3.0 (University of Texas Health Science Ceneter, San Antonio, TX) is

an image processing and analysis program for displaying, editing, and analyzing
grey scale images that was used to measure the fiber diameter and pore size of
each concentration for each of the patella groups at all concentrations.
10. Using ImageTool3.0, the fiber diameter of each picture was measured using a
point-to-point method at 60 measurements per picture. One point was started on a
side of the fiber that measured the perpendicular distance to the other side of the
fiber. For pore size, the same program and method was used, but the distance that
existed between the fibers was measured from all angles at a total of 60
measurements per picture.
Statistical Analysis
The statistical analysis of the results for the comparison of the percent yield of the
three cartilage groups and both the fiber diameter and pore size for the various
concentrations of the electrospun mats was done utilizing Tukey's method. JMP Version
5.0.1.2 is statistical discovery software designed by SAS Institute, Inc. that was used to
determine the comparison of the significant difference(s) of the results that were under
analysis.

Results

Yield for the First Extraction
Below, in Figure 9, the percent yield results for the first extraction can be seen.
The fetal group had the highest percent yield of 0.67%; the Lampire group had a percent
yield of 0.08%; the Spear group had a percent yield of 0.06%.
Cartilage Chip Age (Source)v a % Yield Type II Collagen

Fetal (Dr.Brand)

140-180 Days Old
(Larrpire)

140-180 Days Old (Spear)

Cartilage Chip Age (Source)

Figure 9: Percent Yield of Extracted Collagen Type I1 for Fetal, Lampire, and Spear
Cartilage Chip Groups

Purity Results for the First Extraction
- -.

Below, in Figure 10, a SDS-Page was performed for all three groups and both a
collagen type I and type I1 standard. It is visually apparent that the banding pattern for
the fetal and Lampire cartilage chip groups match that of the collagen type I1 standard
and not that of the collagen type I standard suggesting the presence of type I1 collagen.
The Spear cartilage group does show a lighter banding pattern that is similar to that of the
collagen type 11 standard, but it is much lighter in color and a bit harder to read
suggesting there may have been an issue of concentrationlcontamination.

Figure 10: SDS-Page for Fetal Bovine Patella Chips, Spear Bovine Patella Chips, and
Lampire Bovine Patella Chips

Electrospinning Results for the First Extraction
When electrospinning the scaffolds for the first extraction, an 18 gauge syringe
needle was used, the voltage was set to 20 kV with minimal current, the mandrel spun at
approximately 800 RPM, and the needle was 3.5 inches away from the mandrel. Due to
lack of material, the fibers were directly spun onto a SEM pellet that was attached to the
spinning mandrel (same electrospinning parameterslmethod was used for the
electrospinning in extraction two and three). The concentrations chosen for the
electrospinning of the scaffolds for the three groups was inconsistent for the initial run
because it was the first time the material had been extracted and dissolved in HFP. The
fetal cartilage group had the highest yield and it also was easily electrospun at low and
high concentrations. Because of this, the material was electrospun at the following
eleven concentrations: 0.05, 0.06, 0.07,0.08, 0.09, 0.10, 0.11, 0.12, 0.13, 0.14, and 0.15
g/mL. The Spear material electrospun at the lower concentrations of 0.04 and 0.06 g/mL,
but was too thick to be electrospun when the concentration was increased. The Lampire
material was electrospun at 0.08,O. 10, and 0.12 g/mL. This material was not viscous
enough to be electrospun when dissolved at the lower concentrations. This was the first
time the material was manipulated for electrospinning, so it was a matter of trial and error
to figure out the best concentrations for spinning of the material. The fact ,that there was
such a small amount of material made the task even more difficult.

Figure 11: SEM of 0.05 g/mL, Collagen Type 11 (Fetal Bovine Cartilage Chip)

Figure 12: SEM of 0.06 g/mL Collagen Type 11 (Fetal Bovine Cartilage Chip)

Figure 13: SEM of 0.07 g/mL Collagen Type I1 (Fetal Bovine Patella Chlp)

Figure 14: SEM 0.08 g/mL Collagen Type I1 (Fetal Bovine Patella Chlp)

Figure 16: SEM 0.10 g/mL Collagen Type I1 (Fetal Bovine Cartilage Chips)

Figure 18: SEM 0.12 g/mL Collagen Type I1 (Fetal Bovine Cartilage Chip)

Figure 19: SEM 0.13 g/mL Collagen Type I1 (Fetal Cartilage Patella Chip)

Figure 20: SEM 0.14 g/mL Collagen Type I1 (Fetal Bovine Cartilage Chip)

Figure 21: SEM 0.15 g/mL Collagen Type I1 (Fetal Bovine Cartilage Chlp)

Figure 22: SEM 0.04 g/mL Collagen Type I1 (Spear Bovine Patella Chp)

Figure 23: SEM 0.06 g/mL Collagen Type I1 (Spear Bovine Patella Chip)

Figure 24: SEM 0.08 g/mL Collagen Type I1 (Lampire Bovine Patella Chp)

Figure 25: SEM 0.10 g/mL Collagen Type I1 (Lampire Bovine Patella Chip)

Figure 26: SEM 0.12 g/mL Collagen Type II (Lampire Bovine Patella Chip)
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Fiber and Pore Measurement for the First Extraction
The data that was utilized to create the graphs in the figures 27 and 28 seen
below, the statistics for both the fiber diameter and pore size can be calculated. Using the
Tukey's W procedure, the values for the mean fiber diameter are significantly different
between all concentrations for the fetal cartilage chip group except 0.05 and 0.06,0.08
and 0.06,0.07 and 0.08,O.14 and 0.1 1 and 0.12 g/rnL. The values for fiber diameter
were all significantly different for the Lampire and Spear group. When analyzing pore
size, the fetal cartilage chip group utilizing Tukey's W procedure the values were all
significantly different except 0.06 and 0.07,0.06 and 0.08,O. 10 and 0.11 and 0.12 g/mL.
For the Larnpire and Spear groups, the pore size values were all significantly different.
These values were all calculated with a = 0.05.
Fiber Diameter for Type II Collagen Extraction #I

Lampire

Concentration (g type II colllmL HFP)

Figure 27: Fiber Diameter Comparison Results for Collagen Type I1 Extraction # 1
Pore Size Results for Collagen Type I1 Extraction #1

Pore Size for Collagen Type II Extraction #I
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Figure 28: Pore Size Results for Collagen Type I1 Extraction #1
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Yield Results for the Second Extraction
Below, in Figure 29, the percent yield results for the second extraction can be
seen. The Spear group had the highest percent yield of 0.045%; the Larnpire group had a
percent yield of 0.031%; the fetal group had a percent yield of 0.014%.
Cartilage Chip Age(Souroe) v a %Yield Type I1 Collagen

Fetal (Dr.Brand)

140-180 Days Old
(Lamre)

140-180 Days Old (Spear)

Cartilage Chip Age (Source)

Figure 29: Percent Yield of Extracted Type I1 Collagen for Fetal, Lampire, and Spear
Cartilage Chip Groups
Purity Results for the Second Extraction
There are no purity results for the second run. The liquid material from the last
dialysis did not have a collagen concentration high enough to show a banding pattern
when the SDS-Page was performed. There was not enough material to make an attempt
to spin the material and to dissolve material for an SDS-Page. Because actually
electrospinning the material is the first priority, the small amount of lyophilized end
material was used for the attempt to spin the material from the three batches.

-

Electrospinning Results for the Second Extraction
Again, for this run, the electrospinning results were inconsistent due to the small
amounts of material that were extracted from the three groups. The ideal concentrations
were electrospun (0.06,0.08,0.10, and 0.12 g/mL), but only the Lampire bovine cartilage
chip group gave a yield of lyophilized collagen type I1 material in an amount large
enough for the electrospinning procedure. There were still errors present in the
procedure.

Figure 30: SEM 0.06 g/mL Collagen Type I1 (Lampire Bovine Patella Chip)

Figure 31: SEM 0.08 g/mL Collagen Type 11 (Lampire Bovine Patella Chip)

Figure 32: SEM 0.10 g/mL Collagen Type I1 (Lampire Bovine Patella Chip)

Figure 33: SEM 0.12 g!mL Collagen Type I1 (Lampire Bovine Patella Chip)
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Fiber and Pore Measurement for the Second Extraction

Utilizing the values used to create the graphs below in Figures 34 and 35, the
statistics for fiber diameter and pore size can be calculated. Using the Tukey's W
procedure with a a = 0.05, the values for the mean of all concentrations for the fiber
hameter and pore size for the second run of the collagen type I1 extraction were
significantly different.
Fiber Diameter for Collagen Type II Extraction #2
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Figure 34: Fiber Diameter Results for Collagen Type I1 Extraction #2

Pore Size for Collagen Type II Extraction #2

0.06

0.08

0.1

Concentration (g Type II ColllmL HFP)

Figure 35: Pore Size Results for Collagen Type 11Extraction #2
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Yield Results for the Third Extraction
Below, in Figure 36, the percent yield results for the third extraction can be seen.
The Spear group had the highest percent yield of 0.64%; the Lampire group had a percent
yield of 0.18%; the fetal group had a percent yield of 0.14%.
Cartilage Chip Age(Source) v9 %Yield Type II Collagen
P

S

Fetal (Dr.Brand)

140-180 Days Old
(Lamre)

14&180 Days Old (Spear)

Cartilage Chip Age (Source)

Figure 36: Percent Yield of Extracted Collagen Type I1 for Fetal, Larnpire, and Spear
Cartilage Chlp Groups
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Purity Results for the Third Extraction

When analyzing the SDS-Page below in Figure 37, it is visibly apparent that the
banding pattern for all three of the cartilage chip groups matches that of the collagen type
I1 standard. This allows us to conclude that the extracted type I1 collagen has a high level

of purity. The banding pattern for the three groups does not match that of the type I
collagen standard, suggesting that there is little type I collagen contamination.

Figure 37: SDS-Page for Fetal Bovine Patella Chips, Spear Bovine Patella Chips, and

Lampire Bovine Patella Chips

.

Electrospinning Results for the Third Extraction
For this final run, all three groups were electrospun at the four desired
concentrations of 0.06, 0.08,O. 10, and 0.12 g/mL HFP and a comparison of the scaffold
characteristics was possible.

Figure 38: SEM 0.06 g/mL Collagen Type I1 (Fetal Bovine Cartilage Chip)

Figure 39: SEM 0.08 g/mL Collagen Type I1 (Fetal Bovine Cartilage Chips)

Figure 40: SEM 0.10 g/mL Collagen Type I1 (Fetal Bovine Cartilage Chip)

Figure 41: SEM 0.12 g/mL Collagen Type I1 (Fetal Bovine Cartilage Chip)

Figure 42: SEM 0.06 g/mL Collagen Type I1 (Spear Bovine Patella Chip)

Figure 43: SEM 0.08 g/mL Collagen Type I1 (Spear Bovine Patella Chip)

Figure 44: SEM 0.10 g/mL Collagen Type I1 (Spear Bovine Patella Chip)

Figure 45: SEM 0.12 g/mL Collagen Type 11 (Spear Bovine Patella Chip)

Figure 46: SEM 0.06 g/mL Collagen Type I1 (Lampire Bovine Patella Chip)

a's-

&
'

---

Figure 47: SEM 0.08 g/mL Collagen Type I1 (Lampire Bovine Patella Chip)

Figure 48: SEM 0.10 g/mL Collagen Type I1 (Lampire Bovine Patella Chip)

Figure 49: SEM 0.12 g/mL Collagen Type I1 (Larnpire Bovine Patella Chip)
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Fiber and Pore Measurement for the Third Extraction
Utilizing the data used to create the graphs below in Figures 50 and 51, the
statistics for the fiber diameter and pore size can be calculated. Using the Tukey's W
procedure with an a = 0.05, the values for the fiber diameter for the Lampire, Spear and
fetal cartilage chip groups at all concentrations are all significantly different from one
another withn each group. When analyzing the pore size for each of the groups in the
same manner, the values for the Larnpire and fetal cartilage chlp groups are all
significantly different fiom one another at all concentrations. For the Spear group, the
values are all significantly different from one another except for the concentrations of
0.06 and 0.08 g/mL, whlch are not significantly different.
Fiber Diameter for Collagen Type II Extraction #3
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Figure 50: Fiber Diameter Results for Collagen Type I1 Extraction #3
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Figure 51: Pore Size Results for Collagen Type I1 Extraction #3
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Overall comparison for all extractions for fiber diameter and pore size
The following graphs in Figures 52 thru 57 visually show how the fiber diameter
and pore size compare to one another for the three extractions. For the fetal and Spear
groups, there will only be two extraction groups for comparison of both fiber diameter
and pore size because the second extraction only yielded material for the Lampire group.
Fiber Diameter for Extraction #I
vs. #3 (Fetal)

1 + Extraction #l
/
1 m Extraction #3 /

I

Concentration (g Coll Type IlImL HFP)

Figure 52: Fiber Diameter Comparison for Fetal Cartilage Chips
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Figure 53: Fiber Diameter Comparison for Lampire Cartilage Chips
Fiber Diameter for Extraction # I vs. #3 (Spear)
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Figure 54: Fiber Diameter Comparison for Spear Cartilage Chips
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Figure 55: Pore Size Comparison for Fetal Cartilage Chps
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Figure 56: Pore Size Comparison for Lampire Cartilage Chips
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Figure 57: Pore Size Comparison for Spear Cartilage Chips

Statistical Analysis
Below, in Figure 58, the Tukey procedure with an a = 0.05 is used to assess
whether the Lampire, Spear, and fetal cartilage chip groups are significantly different
from one another according to fiber diameter. It was determined that the Spear group is
significantly different from the Lampire and fetal groups in terms of fiber diameter. The
Lampire and fetal cartilage chip groups are not significantly different from one another.
Below, in Figure 59, the Tukey procedure with an a = 0.05 is used to assess
whether the Lampire, Spear, and fetal cartilage chip groups are significantly different
from one another according to pore size. The same relationship exists for the pore size as
the fiber diameter. The Spear group is significantly different from both the fetal and
Lampire groups. The fetal and Lampire cartilage chips groups are not significantly
different from one another in terms of pore size.
When analyzing the different concentrations for all three groups combined
according to the fiber diameter using the Tukey's procedure with an a = 0.05, all
concentrations (0.06,0.08,0.10, and 0.12 g/mL) are significantly different from one
another (Figure 60). In Figure 61, the different concentrations for all three of the
cartilage chip groups combined are analyzed according to pore size in the same manner
as was done for fiber diameter in Figure 60. For the pore size of all three groups, the
concentrations of 0.06 and 0.08 are not significantly different. The concentrations of
0.10 and 0.12 are also not significantly different. The two sets of concentrations are
significantly different from each other in terms of pore size when all three of the cartilage
chips groups are combined.
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All Pairs
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Collagen Type I1 Extraction

Figure 58: Tukey's One Way Analysis of the Lampire, Spear, and Fetal Cartilage Chip
Groups According to Fiber Diameter
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Figure 59: Tukey's One Way Analysis of the Lampire, Spear, and Fetal Cartilage Chlp
Groups According to Pore Size
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Figure 60: Tukey's One Way Analysis of Fiber Diameter for Lampire, Spear, and Fetal

Cartilage Chps According to Concentration
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Figure 61: Tukey's One Way Analysis of Pore Size for Lampire, Spear, and Fetal

Cartilage Chips According to Concentration

Discussion
For the first run of the collagen type I1 extraction, there were three major mistakes
that were made, which led to much smaller end yields than were expected. The first
mistake was the blender used to grind the cartilage chips in step #2. Only a Hamilton
Beach 14 speed blender (model #54252B) was used with 400 Watts of power (0.5
horsepower), but a Waring blender with a minimum of three horsepower was necessary
for the proper maceration of the cartilage chips. The type I1 collagen cannot be fully
extracted if the pieces of cartilage are too large. The blender utilized barely made the
pieces any smaller for this first extraction then when the pieces were cut by hand. The
second mistake was made in step # 10, which was that the pepsin extracted collagen type
I1 supernatant was not left out at room temperature overnight after the 5 M NaCl was
added. Instead, the solution was placed in the refrigerator because of the possibility of
denaturalization of the material. Leaving this solution out at room temperature actually
precipitates the collagen. Lastly, when preparing the sample solution for the SDS-Page,
the material used was the actual dialyzed collagen solution from step #22. When the final
material (liquid form before freezing and lyophilization) from step #22 was used, there
was no way to measure the concentration of type I1 collagen in the dilute acetic acid
because it was so low (difficult to detect). If the lyophilized collagen was used (as was
done in the third extraction), the dissolved concentration is known and can be made equal
to that of the standards.
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When comparing the SEM pictures for the fetal cartilage chip group from the
first extraction, Figures 19,20 and 21 (0.13,O.14,O.15 g/inL) are a bit different from the
rest. There is a combination of smaller and larger fibers. This could be due to the fact
that these are the higher concentrations and the dissolved material was very thick and was
sputtering out of the needle. It is also possible that the material may not have been mixed
properly due to the presence of a high level of viscosity or there may have been a
contamination issue.
For the second extraction, the correct blender was utilized for the second step of
the collagen type TI extraction. A Waring CB 15 three horsepower blender was used to
blend the chips into a fine milkshake consistency. There was still a problem with getting
an acceptable yield for the three batches and that was due to the addition of salt to begin
the precipitation in step # 10 of the collagen type I1 extraction process. The speed of the
addition of the 5M salt to the solution is critical. It must be added slowly and not create
any disturbance in the solution (bubbles). During this extraction, the carboy of 5M NaCl
was placed above the container of the stirring solution and to allow the salt to drip into
the container below in a stream-like fashion (not a slow drip). The speed of the addition
was too fast, which can cause an improper precipitation of the collagen type 11. The
solution was left out at room temperature and a there was an actual cloudiness in the
solution, which was a visible sign that the collagen type I1 had precipitated. This was not
seen in the first extraction. For the first extraction the solution was completely clear
when taken out of the refrigerator after the salt precipitation. This proved that leaving the
solution at room temperature overnight does play a vital role in the collagen type I1
precipitation. In the second extraction, a SDS Page was performed, but absolutely
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nothing showed up on the gel. This was due to the mistake of not actually taking the
lyophilized collagen and dissolving it in dilute acetic acid to be used in the SDS Page.
Instead, we used the liquid material from step #22 which will have a very small collagen
concentration (also unknown concentration). The concentration was even smaller for this
processing run as compared to the first as is shown by the smaller calculated percent
yield for the three batches. Once this was realized, it was too late to repeat the SDS Page
because all of the lyophilized collagen type I1 was used to make an attempt to spin the
type I1 collagen from the three groups of cartilage chips. Again, for this run, the
electrospinning results were inconsistent due to the small amounts of material that were
extracted from the three groups. The ideal concentrations were electrospun (0.06,0.08,
0.10, and 0.12 g/mL), but only the Lampire bovine cartilage chip group gave a yield of
lyophilized collagen type I1 material in an amount large enough for the electrospinning
procedure.
After two trials, we were able to detect and correct many errors. For the third
extraction, the correct blender was used, the salt was added at a drip by drip speed when
precipitating the collagen type 11, and the material was left out overnight at room
temperature after the salt precipitation. There was enough end product from all three
cartilage chip groups to perform both electrospinning at all four concentrations and a
SDS-Page. The end product was greatest for this extraction for all three cartilage chip
types. This extraction allowed us to create much more comparable results because the
same four concentrations were electrospun for all three groups and the same
concentration of type I1 collagen actual lyophilized end product dissolved in dilute acetic
acid was used to run the SDS-Page. In the first trial, only the fetal bovine chips spun well
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while the Lampire and Spear chips could only be spun at certain concentrations. In the
and the
second trial, only the Lampire chips produced material that could be electrosp~~n
material from the other two groups were wasted during the attempt to spin scaffolds,
leaving no material for purity testing. This final third extraction yielded enough material
to both run a SDS page to assure the material was pure collagen type I1 without any type I
contamination and to electrospin each of the three cartilage chip groups at the desired
concentrations of 0.06,0.08,0.10,and 0.12 g/mL HFP for the analysis of fiber diameter
and pore size.
The main goal of this experiment was the extraction and electrospinning of type I1
collagen from the cartilage of bovine specimens. This was achieved for bovine
specimens ranging from fetal to six months old. It was proven that through the
manipulation of concentration of the dissolved collagen type I1 in HFP, the fiber diameter
and pore size can be increased or decreased according to the desired size. This allows the
collagen type 11 scaffold to have the ability to suit any need according to the size of the
cell that will need to infiltrate into the scaffold. An optimal scaffold can be spun once the
proper parameters are determined. Electrospinning is a method of creating scaffolds that
has many variables including voltage, mandrel speed, distance between the mandrel and
needle, and pump speed. The machine used to create the scaffolds in this experiment has
room for error when adjusting the mandrel speed. There is no precise way to assure that
the mandrel is spinning at the exact same RPM for the duration of the time the scaffold is
constructed and there may be a difference when electrospinning one scaffold as compared
to another at the same RPM setting. It was proven in the experiment that for all three
cartilage groups, both fiber diameter and pore size increase as concentration increases.
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As concentration decreases the opposite occurs. This is a highly important factor in
-

-

tailoring an ideal matrix.
Both temperature and humidity may also affect the electrospinning of the
scaffolds. Sometimes there may also be a charge build-up at the site where the material
leaves the end of the syringe that is to be deposited onto the mandrel. A system design
that is more highly enclosed with a highly precise way to measure the consistency at
which the mandrel rotates may give the ability to have a much more regular fiber
diameter and pore size. There is still quite a bit of variation in the scaffolds that were
electrospun for this project.
The ability to electrospin an entire scaffold and not just onto a SEM pellet is
highly important. Due to the small yields that were extracted during this experiment, we
were unable to do so, but the processing technique has now been refined. Once the
material is electrospun into mats, the material properties can be analyzed according to the
varying concentration utilized to electrospin the mats.
The yield results for the three processing runs were inconsistent. This was due to
the fact that there were many processing errors that were worked out along the way. For
the first run, the fetal group had the highest percent yield, but for both the second and
third run, the Spear cartilage chip group had the highest yield. This could be due to the
possibility that the chips were manually scraped and had no contamination of blood
vessels or bone marrow. For the second and third processing runs, the fetal chip group
had the lowest yield and the Lampire chip group was in the middle.
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Future Work
There is a great deal of work that needs to be done now that it has been proven
that type I1 collagen can be extracted and electrospun. Articular cartilage poses a great
problem to the aging society. The idea that collagen type I1 can be electrospun into any
desired shape and size and manipulated to have the desirable pore size and fiber diameter
for the seeding of chondrocytes gives great possibility for a tissue engineered product.
The testing of the mechanical properties is highly important because it must be durable
enough to resist high loads, yet porous eiiough to allow for the synovial fluid to flow in
and out of the tissue to deliver the needed nutrients to the chondrocytes. It is likely that
the collagen type I1 scaffold will need to be blended with a polymer to increase the
strength. There are many FDA friendly polymers that are available that have minimal
rejection from the body, such as PDS. Once the mechanical properties for tensile
strength, modulus of elasticity, peak load, peak stress, and strain at break are determined
to be the best match to that of the articular cartilage tissue inside the body, then this
material will be chosen for the seeding of chondrocytes. Next, the concentration of this
material must be chosen. The desired pore size and fiber diameter for optimal infiltration
and regeneration of chondrocytes must be determined and the scaffold can be
manipulated by varying the concentration to fit within these parameters. The scaffold
should then be seeded with chondrocytes to see how the cells interact with the material.
The use of a combination of a natural and synthetic material would be optimal
because the natural material will help with the possibility of rejection and will also be
recognizable as "home" for the cells. Cells will be able to identify this familiar material
as being similar to that of their natural environment. The adchtion of the synthetic
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material will allow for a better determination of degradation rate inside the body. It
will also increase the consistency of the material. Synthetic materials are produced in a
highly regulated fashion, whereas the extraction of natural materials can often times be
inconsistent from batch to batch.
The addition of growth factors or the use of stem cells is also an additional
possibility once the optimal scaffold has been chosen. Once the scaffold has proven to
allow chondrocytes to infiltrate, proliferate and regenerate, the scaffold will be ready for
testing in vivo. The idea of a tissue engineered product made predominately of collagen
type I1 could give many possibilities for the remedy of osteoarthritis or any other injuries
to the joints of aging individuals.
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